It has been reported that inflammatory signals like IFN-γ, acting through IRF1, play a significant role in promoting this splicing switch, particularly at the invasive front of breast tumors, suggesting that the tumor microenvironment can modulate immune evasion through this mechanism [168]. The gene discussed is IRF1; the disease is neoplasm.